new molecules and indications for glp 1 medicines Ozempic other GLP-1 drugs were initially understood as a metabolism breakthrough: that act like hormones to control hunger, blood sugar and weight. But as researchers probe deeper into how the Five Unexpected New Uses for

Health Canada has approved two generic manufacturers Dr

Read article 17 May 2026 A practical guide to understanding nutrition estimates and using them as helpful support rather than exact measurement

Tumor Necrosis Factor Alpha Blockade and Multiple Sclerosis: Exploring New Avenues

The survey, completed in February and March 2026 by 105 Business Group on Health members, found that 67% of large employers currently cover GLP-1s for weight management

[,] Considering these difficulties, prevention of the disease becomes even more valuable, as it is often preferable to prevent a disease rather than seek a cure for it

UK Monitoring Guide Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for type 2 diabetes mellitus and weight management